Kristin Knight, M.S.

Oregon Health & Science University UCEDD
Institute on Development & Disability
Oregon Health & Science University
707 SW Gaines St.
Portland, OR 97239
 
Phone: 503-494-2061
Email: gilmerk@ohsu.edu
Login to Update Your Profile
Last Updated: August 25, 2017

Kristin Knight
 

Primary Activity Coordinators: Pediatric Services
Research
Discipline Coordinators: Audiology
Specialty Resource Contacts: Ototoxicity
 
Discipline(s): Audiology
 
AUCD Council Membership: No Council Membership
 
Research: Cisplatin Ototoxicity, Ototoxicity monitoring in children, and diagnostic evaluation of hearing in infants.
Education: M.S., Portland State University, Portland, OR, 1995
Service: American Speech-Language Hearing Association, Oregon Speech-Language Hearing Association, Acoustical Society of America, American Academy of Audiology, American Auditory Society, Children's Oncology Group, and Hands & Voices of Oregon.

Vita/Bio

CURRICULUM VITAE
OREGON HEALTH SCIENCES UNIVERSITY

 

NAME
Kristin Knight
DATE 12/10/2013

 

PRESENT POSITION AND ADDRESS

Academic Rank:
Associate Professor of Pediatrics

Department/
Division:
Department of Pediatrics, Institute on Development and Disability
School of Medicine

Professional Address:
CDRC 707 SW Gaines
Portland OR 97239

E-Mail Address:
gilmerk@ohsu.edu

II. EDUCATION
Undergraduate and Graduate (Include Year, Degree, and Institution):
1993, Portland State University, Bachelor of Science, Speech and Hearing Science

1995, Portland State University, Master of Science, Speech and Hearing Science
Terminal degree in the field at that time.

Certification (Include Board, Number, Date, and Recertification):
Certificate of Clinical Competence in Audiology (CCC-A), American Speech-Language Hearing Association (ASHA) #09128998, 1995 - present. Recertification date: 12/31/2013

Licenses (Include State, Date, Status, Number, and Renewal Date):
State of Oregon Audiology License, Board of Examiners in Speech Pathology and Audiology, #22035, 1999 - present. Renewal date 1/30/2014

III. PROFESSIONAL EXPERIENCE

Academic (Include Year, Position, and Institution):

2011- Present Audiology Training Coordinator, Leadership on Neurodevelopmental and Related Disabilities (LEND), Institute on Development and Disability, Portland, Oregon

2007 - Present Assistant Professor, Pediatric Audiology, Department of Pediatrics, Institute on Development and Disability, Child Development and Rehabilitation Center and Doernbecher Children's Hospital, Oregon Health and Science University, Portland Oregon.

1999- 2007 Instructor, Pediatric Audiology, Department of Pediatrics, Institute on Development and Disability, Child Development and Rehabilitation Center and Doernbecher Children's Hospital, Oregon Health and Science University, Portland Oregon.

2002 - Present Adjunct Instructor, Department of Speech and Hearing Science, Portland State University, Portland, Oregon


Administrative (Include Year, Position, and Institution):
2006 - Present Discipline Director, Pediatric Audiology, Department of Pediatrics, Institute on Development and Disability, Child Development and Rehabilitation Center and Doernbecher Children's Hospital, Oregon Health and Science University, Portland, Oregon

2003 -2006 Administrative Coordinator, Pediatric Audiology, Department of Pediatrics, Institute on Development and Disability, Oregon Health and Science University, Portland, Oregon

Other (Include Year, Position, and Institution):

1996 - 1999 Educational Audiologist, Vancouver School District #37, Vancouver, WA.

1998 Clinical Audiologist, Otolaryngology Outpatient Clinic, Oregon Health and Science
University, Portland, Oregon

1995- 1996 Audiology Clinical Fellowship, Leadership on Neurodevelopmental and Related Disabilities, Child Development and Rehabilitation Center, Oregon Health and Science University, Portland, OR.

IV. Honors and Awards
2007 Leadership Education in Neurodevelopmental and Related Disabilities Distinguished Alumna Award

V. SCHOLARSHIP

Area(s) of Research/Scholarly Interest:
Assessment, treatment, and prevention of ototoxicity in children receiving chemotherapy
Diagnosis and management of auditory neuropathy spectrum

Grants and Contracts:

Title: Two-Compartment Models to Improve Brain Tumor Therapy
NIH #5 R01 NS033618
PI: Dr. Edward Neuwelt
NIH-NINDS funding: $295,800
Dates: 3/31/2003 - 3/30/2014
.1 FTE
Consultant and study audiologist. The goals of this project are to evaluate the potential for dose intensification and anti-tumor efficacy of chemotherapeutics, cytoprotectors and chemoenhancers in two models of brain tumor therapy. Work includes study of ototoxicity and otoprotection in a rat tumor model and clinical research in patients receiving platinum chemotherapy.

Title: Community Clinical Oncology Program Grant
National Childhood Cancer Foundation/CureSearch
PI: Dr. Kellie Nazemi
NCCF funding:
Dates: 7/01/2005 - 9/01/2012
.1 FTE
Study audiologist and study committee member. The goals of these studies were to evaluate the incidence and severity of hearing loss in children treated with cisplatin chemotherapy at Children's Oncology Group-affiliated treatment centers in the United States and Canada (COG ACCL05C1) and to evaluate the efficacy of sodium thiosulfate for cisplatin otoprotection in pediatric cancers (COG ACCL0431).

COG ACCL05C1: A Groupwide Prospective Cohort Study of Risk and Measurement of Ototoxicity in Children receiving Cisplatin Chemotherapy. Study activated 5/2007 and closed 9/2012, 301 subjects enrolled.

COG ACCL0431: A randomized phase III study of sodium thiosulfate for the Prevention of Cisplatin-Induced Ototoxicity in Children. Study activated 6/2008 and closed 9/2012, 131 subjects enrolled.

Work included development of clinical protocols and audiologic methods to monitor and study ototoxicity within the context of a multi-center clinical trial, assisted in development of systems to collect and evaluate audiologic data submitted from participating centers, contributed to study concept summaries reviewed by the Children's Oncology Group, and study protocols. Study committee membership included regular conference calls and meetings with the Principal Investigators and committee members. Communication with audiology departments at participating institutions regarding audiologic test protocol and protocol deviations, oversight of audiologic data submitted by institutions, and central audiologic review of all hearing data including quality assurance, data management, evaluation of results, and ototoxicity grading. Provided institutional audiologic review and reporting for all subjects enrolled at OHSU. Currently participating in analysis of results and was invited to be the primary author of manuscript for COG ACCLO5C1.

Publications/Creative Work:
Peer-reviewed
Landier, W, Knight KR, Wong L, Lee J, Thomas O, Kim H, Kreissman SG, Schmidt ML, Chen L, London WB, Gurney JG, Bhatia S. Ototoxicity in Children with High-Risk Neuroblastoma - Prevalence, Risk Factors, and Concordance of Grading Scales: A Report from the Children's Oncology Group. Journal of Clinical Oncology, January 13, 2014 doi: 10.1200/JCO.2013.51.2038.

Brock P, Knight KR, Freyer D, Campbell KCM Steyger PS, Blakley BW, Rassekh T, Chang KW, Fligor B, Sullivan M, Neuwelt EA. Platinum-induced ototoxicity in children: a consensus review on ototoxicity, otoprotection and monitoring. Journal of Clinical Oncology, 30(19), 2408-17, 2012.

Guillaume DJ, M.D., Knight KR, Kraemer D, Bardo D, Neuwelt EA. Cerebrospinal Fluid Shunting and Hearing Loss in Patients Treated for Medulloblastoma. Journal of Neurosurgery Pediatrics, Apr 9(4): 421-7, 2012

Jahnke K, Kraemer DF, Knight KR, Fortin D, Bell S, Doolittle ND, Muldoon LL, Neuwelt EA. Intrarterial chemotherapy and osmotic blood-brain barrier disruption for patients with embryonal germ cell tumors of the central nervous system. Cancer 112(13):581-588, 2008

Knight KR, Kraemer DF, Winter C, Neuwelt EA. Early changes in auditory function as a result of platinum chemotherapy: use of extended high frequency audiometry and evoked distortion product otoacoustic emissions in pediatric ototoxicity monitoring. Journal of Clinical Oncology, 25(10): 1190-1195, 2007.

Neuwelt EA, Gilmer Knight K, Lacy C, Nicholson HS, Kraemer DF, Doolittle ND, Hornig G, Muldoon LL. Toxicity Profile of Delayed High Dose Sodium Thiosulfate in Children Treated with Carboplatin in Conjunction with Blood-Brain-Barrier Disruption. Pediatric Blood & Cancer Aug;47(2):174-82, 2006

Gilmer Knight KR, Kraemer DF, Neuwelt EA. Ototoxicity in Children Receiving Platinum Chemotherapy: Underestimating a commonly occurring toxicity that may impact academic and social development. Journal of Clinical Oncology 23(34): 8588-8596, 2005.

Non-peer-reviewed
Chang KW, Knight KR, Brewer C, Brock P, Brooks B, Grimes A, Landier W, Paulino A, Rajput K, Sung L. Clinical study of ototoxicity in children. Paper presented at the SIOP Ototoxicity Consensus Conference, 42nd Congress of the International Society of Pediatric Oncology, Boston, 2010.

Knight, KR. Hearing loss in cancer survivors treated with cisplatin chemotherapy. Oncology Nurse Edition 22(4): 35-37, 2008

Knight KR, Petcher L. The New Law for Newborn Hearing Screening: What it Means and What to Expect, The Doernbecher Journal, Vol. 6, No. 3, 2000

Chapters
Knight K, Durham H, Carmichael N, Plapinger D. (2008) Audiological assessment of children with autism spectrum disorders in B Buckendorf (Ed) Autism: A Guide for Educators, Clinicians, and Parents. Greenville, South Carolina, Thinking Publications.

Abstracts
Freyer DR, Chen L, Pollock BH, Knight K, Bliss B, Ramdas J, VanSoelen M, VanHoff D, Wiernikowski J, Rassekh R, Sung L, and Neuwelt EA. Prevention of Cisplatin-induced Hearing Loss in Children by Sodium Thiosulfate (STS): a Report from the Children's Oncology Group. American Society of Clinical Oncology (ASCO) Annual Meeting, Chicago, 6/2014

Knight KR, McMillan GP, Martin D, Nelson E, Neuwelt EA, Winter C, Dille M. Long term variability of distortion-product otoacoustic emissions (DPOAEs) in children. American Auditory Society Annual Meeting, Scottsdale AZ, 3/2014.

Stefi E, Brock P, Chang KW, Knight KR, Neuwelt EA, Rajput K. Validation of The SIOP Boston ototoxicity Scale- An international scale for the evaluation of platinum-induced ototoxicity in children. The 45th Congress of the International Society of Paediatric Oncology (SIOP 2013) Hong Kong 9/2013

Lee DH, Knight KR, Chang KW. Validity of audiogram threshold interpolation in pediatric oncology patients. American Society of Pediatric Otolaryngology 28th Annual Meeting, Arlington, VA, 4/2013

Landier W, Knight KR, Wong FL, Lee J, Thomas, O, Kim H, Kreissman S, Schmidt ML, Chen L, London WB, Bhatia S, Gurney J. Ototoxicity in children with high-risk neuroblastoma: Prevalence, risk factors, and concordance of grading scales - A report from the Children's Oncology Group (COG), American Society of Clinical Oncology (ASCO) Annual Meeting, Chicago, 6/2011

Guillaume D, Knight KR. Hearing loss and cerebrospinal fluid shunting in children with medulloblastoma, 42nd Congress of the International Society of Pediatric Oncology. Boston, 10/2010

Guillaume D, Knight KR. CSF shunting and ototoxicity in children treated for medulloblastoma, Western Neurosurgical Society Annual Meeting, 2008

In process/in preparation, unfunded
Stefi E, Brock P, Chang KW, Knight K, Neuwelt EA, Ranja K, Rajput L, Rajput K. Validation of the SIOP Boston Ototoxicity Scale: An international scale for the evaluation of platinum-induced ototoxicity in children. Manuscript in preparation.

Grewal S, Knight KR, Bass J. Evaluation and management of hearing loss following therapy for childhood and adolescent cancers. Manuscript in preparation.

Chang KW, Knight KR, Landier L, Bhatia S. Validation of the SIOP Ototoxicity Scale. Retrospective analysis of audiologic results obtained on COG 3973 to assess the feasibility and validity of the SIOP Ototoxicity Scale and comparison with widely-used existing ototoxicity grading criteria. Statistical analysis in process.

Knight KR. Long-term audiologic outcomes in children treated with cisplatin chemotherapy, retrospective study of the prevalence of hearing loss progression after cancer treatment in patients treated at OHSU with platinum chemotherapy in childhood. IRB study approval received 8/2013.

SIOPEL 6: A multi-centre open label randomized phase III trial of the efficacy of Sodium Thiosulphate in reducing ototoxicity in patients receiving Cisplatin chemptherapy for Standard Risk Hepatoblastoma. International Society of Pediatric Oncology- Liver Tumors Study Group ( SIOPEL), study committee member, co-author of study protocol. Study activated 11/2008. International cooperative group study to evaluate the efficacy of STS in reducing the incidence and severity of hearing loss in children treated with cisplatin for hepatoblastoma. Study activated 11/2008, 82/115 patients accrued.

Knight KR, McMillan G, Dille M, Konrad-Martin D, Reavis K, Nelson E, Winter C, Neuwelt EA. Long term variability of distortion product otoacoustic emissions in infants and children, IRB #2217, 2002-current. Study aims are to determine long- term test-retest variability of DPOAEs in infants and children with normal hearing. Data will be used to develop standard errors of measurement and confidence intervals on which to base clinical change criteria for this test in children. Statistical analysis in process.

Research Products
Ototoxicity Database (IRB#1284) Developed with Christiane Winter, 2004. Database designed for prospective collection of audiologic and treatment data from patients undergoing platinum based chemotherapy. The database is used for research aimed at determining factors that place children at higher risk for ototoxicity and identifying clinical indicators of higher individual risk for ototoxic hearing loss, 2005.

Invited Lectures, Conference Presentations or Professorships:
International and National
Knight, KR: Update on phase III clinical trials of Sodium Thiosulfate (STS): Children's Oncology Group ACCL0431 and SIOPEL 6. 19th Annual Neuro-Oncology and Blood Brain Barrier Consortium Meeting: Skamania WA, 3/2013

Knight, KR: Ototoxicity in children with retinoblastoma treated with carboplatin. 19th Annual Neuro-Oncology and Blood Brain Barrier Consortium Meeting: Skamania WA, 3/2013

Knight, KR: Cisplatin ototoxicity in children and ototoxicity monitoring, invited lecture, Utah State University, 1/2013.

Grewal S, Knight KR, McInerney MR, Merchant T. Children's Oncology Group Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancers: Auditory Task Force Report. COG Fall Meeting, Atlanta, September 2012

Knight, KR: Sodium Thiosulfate (STS) for the Prevention of Ototoxicity Induced by Platinum Chemotherapy in Pediatric Patients Pediatric Hearing Damage. Food and Drug Administration: Center for Drug Evaluation and Research, Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee Meeting (ODAC). Silver Spring, MD, 11/2011

Knight, KR, Brewer C, Brooks B, Grimes A, Fligor B: Guidelines for monitoring and grading pediatric ototoxicity. American Academy of Audiology: Audiology Now. Chicago, 4/2011.

Knight KR, Chang K. Ototoxicity monitoring and grading in children. 42nd Congress of the International Society of Pediatric Oncology. Boston, 10/2010

Grewal S, Knight KR, McInerney MR, Merchant T. Children's Oncology Group Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancers: Auditory Task Force Report. COG Fall Meeting, Dallas, 9/2010

Knight, KR. Methods of evaluating ototoxicity in children and adults with malignant brain tumors. 12th Annual Neuro-Oncology and Blood Brain Barrier Consortium Meeting: Delivery and Neurotoxicity Issues in CNS Malignancy. Sunriver Resort, Bend, Oregon, 3/2006

Knight KR. Pediatric Ototoxicity Monitoring. National Center for Rehabilitative Auditory Research Bi-annual Conference. Portland Oregon, 9/2005

Knight, KR. Ototoxicity in Children Treated with Cisplatin. International Society of Pediatric Oncology Annual Meeting, Vancouver, British Columbia, 9/2005

Knight, KR. Ototoxicity in Children Receiving Platinum Chemotherapy: Underestimating a commonly occurring toxicity that may impact academic and social development. Poster presentation. 11th Annual Neuro-Oncology and Blood Brain Barrier Consortium Meeting: Nanomedicine and Nanotechnology. Portland, Oregon, 3/2005

Knight, KR. Ototoxicity in Children Receiving Platinum Chemotherapy: Underestimating a commonly occurring toxicity that may impact academic and social development. Poster presentation. Annual meeting of the American Society for Clinical Oncology. Orlando, Florida, 9/2005

Knight, KR. Ototoxicity in Children Receiving Platinum Chemotherapy: Incidence and Implications. 10th Annual Neuro-Oncology and Blood Brain Barrier Consortium Meeting: New Frontiers in Translational Research and the Blood Brain Barrier. Sunriver Resort, Bend, Oregon, 3/2004

Regional and Local
Knight, KR. Diagnosis and Management of Significant Hearing Loss in Children. Neuroscience Seminar, OHSU, 4/2013

Knight, KR, Buckendorf B. Giving Difficult News: How to do it with Skill and Compassion. Pacific University 3/2013, Portland State University 2006-2013 (annual lecture for Counseling in Communication Disorders course); Oregon Speech-Language-Hearing Association Annual Conference, Bend Oregon 10/2009; Oregon and Washington Speech-Language-Hearing Association Annual Conference, Vancouver Washington 10/2006.

Knight, KR. Cisplatin Ototoxicity in Children: Grading and Dose Modifications, Audiology Journal Club, Oregon Health and Science University, 12/2012

Knight KR. Sodium Thiosulfate (STS) for the Prevention of Ototoxicity Induced by Platinum Chemotherapy in Pediatric Patients Pediatric Hearing Damage. Brain Tumor Board, Oregon Health and Science University, 11/2011

Knight, KR. Monitoring and Grading Pediatric Ototoxicity: Oregon Academy of Audiology Fall Conference, Keizer, Oregon, 10/2011.

Knight KR, Middle ear fluid and hearing loss in children with Down syndrome, Northwest Down Syndrome Association, Portland, Oregon, 11/2011

Knight, KR. Can hearing loss from cisplatin ototoxicity be prevented? Continuing education presentation for community audiologists, Portland Oregon, 10/2010

Knight, KR, Ganz C, Merkens M, Rogers B, Zonana J. Challenging Clinical Case: Behavioral/Developmental Delay and the Medical Home, Pediatric Grand Rounds, Oregon Health and Science University, 3/2010

Knight KR. Cisplatin ototoxicity monitoring, Brain Tumor Board, Oregon Health and Science University, 2/2010

Knight KR, Freeman K, Sikora D. Linking Science and Practice. LEND Interdisciplinary Seminar; 9/2010, 9/2009

Knight KR. Current hearing technology for infants and children with hearing loss. Webinar for public health nurses through OSCSHN, 8/2009

Knight KR. ACCL0431 A Randomized Phase III Trial of Sodium Thiosulfate for the Prevention of Cisplatin Ototoxicity in Children. Pediatric Oncology Grand Rounds, Oregon Health and Science University, 9/2008

Knight, KR. Diagnosing hearing loss in infants and young children. Otolaryngology Grand Rounds, Oregon Health and Science University, 8/2008

Knight, KR. Cisplatin and the blood-cochlea barrier, Ototoxicity Journal Club, Oregon Health and Science University 4/2008

Knight, KR, Platinum Ototoxicity. Otolaryngology Grand Rounds, Oregon Health and Science University, 3/2008.

Knight, KR, Pediatric Audiology. Lecture for Advanced Audiology course for graduate and undergraduate students in Speech-Language Pathology and Audiology, Portland State University, 2004, 2005, 2006, 2007, 2008, 2009

Knight, KR, Cisplatin Ototoxicity in Children. Oregon Speech-Language Hearing Association 2007 conference: Advocating for Our Professions, Eugene Oregon, 10/2007

Knight, KR, Cisplatin ototoxicity: clinical perspectives, Ototoxicity Journal Club 8/2007

Knight, KR, Children's Oncology Group Ototoxicity Study: ACCL051. Pediatric Tumor Board, Oregon Health and Science University, 2007

Knight, KR, ACCL051: A Groupwide Prospective Cohort Study of Risk and Measurement of Ototoxicity in Children receiving Cisplatin Chemotherapy. Brain Tumor Board, Oregon Health and Science University, 2007

Knight, KR, Children's Oncology Group Ototoxicity Studies: Can hearing loss from chemotherapy be prevented? Child Development and Rehabilitation Center Grand Rounds, Oregon Health and Science University, Portland Oregon 1/2007

Knight, KR, Assessment and prevention of cisplatin-induced ototoxicity - a new phase III COG study, Pediatric Brain Tumor Board, Oregon Health and Science University, 2005

Knight, KR, Auditory Brainstem Response Testing. Presentation for graduate Audiology course for students majoring in Deaf Education, Lewis and Clark College, 2004

Knight, KR, Audiology and ototoxicity in children receiving chemotherapy. Presentation for high school research mentorship program, Oregon Health and Science University, 2004

Knight, KR, Audiology and Ototoxicity in Brain Tumor Patients, Department of Neurology Grand Rounds, Oregon Health and Science University, 2003

Knight, KR, Case Study: Auditory Dys-Synchrony, Department of Speech-Language Pathology and Audiology, CDRC, Oregon Health and Science University (with Dr. Carol MacArthur), 2003

Knight, KR, Pediatric Audiology, Department of Otolaryngology Grand Rounds, Oregon Health and Science University, 2002 and 2003


VI. SERVICE

Membership in Professional Societies:
American Academy of Audiology
American Speech, Language and Hearing Association
Acoustical Society of America
Children's Oncology Group
Oregon Academy of Audiology


Granting Agency Review Work:
NIH Review: K08 training grant: Regional chemoprotection against cisplatin-induced hearing loss, 2006

NIH Review: R-01 grant: D--methionine as an otoprotectant for the dose limiting ototoxicity of aminoglycosides, 2006

Ad Hoc Review Activities:
Ad hoc reviewer for:
Journal of Clinical Oncology
International Journal of Audiology
Journal of the American Academy of Audiology
Cancer
International Journal of Radiation Oncology Biology Physics
Pediatric Blood and Cancer
Radiation Oncology Journal
Trends in Pharmacological Sciences

American Academy of Audiology Position Paper: Ototoxicity Monitoring: Position Statement and Clinical Guidelines. Provided a written review and recommendations for practice guidelines and position paper regarding ototoxicity monitoring, 12/2008

Oregon Board of Examiners for Speech-Language Pathology and Audiology. Professional written review of audiologic evaluations and recommendations from licensees that the Board was investigating for conformance with community clinical and ethical standards of care for audiology practice, 11/2008 and 8/2009

American Speech-Language-Hearing Association Continuing Education Self-Study Course: Ototoxicity, Audiologic Monitoring and Otoprotection. Provided written review of course content and materials for the American Speech-Language-Hearing Association 5/2006.

Committees:
International/National
Member, Children's Oncology Group Auditory Late Effects Committee, 2008-present
Co-Chair, International Society of Pediatric Oncology: Pediatric Ototoxicity monitoring and grading working group, 2010-2011

Regional
Board Member, Hands and Voices of Oregon, 2012 - Present

Member, Data safety monitoring committee, Prevention of Cisplatin Ototoxicity with the Antioxidant a-Lipoic Acid, Debra Wilmington PI. National Center for Rehabilitative Auditory Research (NCRAR) VAMC. 2007-2011

Member, Parker's Bill Committee. Committee consisting of professionals and parents supporting legislative mandate (Ben Canon, Rep) to require insurance coverage for hearing aids for Oregon children with hearing loss. Co-authored position paper and assisted in drafting bill including soliciting recommendations from pediatric audiologists across the state. Assisted in obtaining professional and parental support including letter-writing and email communication with State Representatives. Testified in support of bill before the Oregon House Healthcare Subcommittee 4/2009. HB 2589 was passed by the Oregon Legislature and signed into law in August 2009. 2007-2009.

Member, Diagnostic Audiology Committee, Oregon Early Hearing Detection and Intervention Program. Regular meetings to discuss procedures and processes for reducing loss to follow-up for infants referring newborn hearing screening , drafted practice guidelines for audiologic assessments of infants who refer newborn hearing screening and re-designed the EDHI diagnostic reporting form, 2007

Member, Committee of pediatric audiologists, educational audiologists, early intervention specialists, and special education administrators that met to propose and draft a revision of the Oregon Administrative Rules for Eligibility for EI services for children with hearing impairment, 2007

Institutional
Discipline Director of Pediatric Audiology, Develop, expand and improve audiology clinical program and services. Develop and revise clinical protocols. Provide staff oversight to ensure credentialing. Monitor clinician productivity and manage clinical schedule to ensure that patient needs are met (5 Pediatric Audiologists, 2 Audiology Externs). Participate in the creation of department budget, manage departmental budget, space, and equipment needs. Compile and report department data as requested. Supervise the purchase, care and repair of clinical equipment and supplies. Recommend hiring, promotion, and salary requirements of audiology staff to CDRC and DCH administration. Identify and remediate problems/conflicts as they arise. Collaborate with support staff and Program Directors regarding provision of Audiology services for Doernbecher and CDRC clinics. Work with support staff and other faculty to triage referrals and coordinate services for patients with complex medical needs. Attend monthly Program and Discipline Directors meetings and Pediatric Development and Rehabilitation meetings. Conduct monthly audiology discipline meetings. 2006-current

Planned and hosted visit by Dr. Kay Chang, Associate Professor, Department of Otolaryngology, Stanford University 10/2010

Chair, LEND Research Committee, 2012-present
Member, Family and Professional Partnerships Committee, LEND, 7/2011 - 2013
Member, LEND Distinguished Alumni Award Committee, LEND, 7/2011 - present
Member, CDRC Group Practice Committee 2008 - 2009
Member, CDRC Budget Committee2008-2009
Member, Speech Language Pathology Director Search Committee 2006
Member, Psychology Search Committee 2005
Member, Speech-Language Pathology Search Committee 2005


Departmental
Chair, Search Committee for LEND Audiology 4th Year Externs, recruitment and hire of 2 1.0 FTE 4th Year
Audiology Externs, annual search 2011-current
Chair, Pediatric Audiology Search Committee, recruitment and successful hire of 1.0 FTE Audiologist for
CDRC/DCH, 2011-2012
Chair, Pediatric Audiology Search Committee, recruitment and successful hire of 1.0 FTE Audiologist for
CDRC/DCH, 2007
Chair, Pediatric Audiology Search Committee, recruitment and successful hire of 1.0 FTE Audiologist for
CDRC/DCH, 2005
Continuing Education Coordinator, Audiology Discipline, 2002-2003

Community Service:
Volunteer, Hands and Voices of Oregon, 2012-current
Portland State University Professional Panel - 2012, 2013
Volunteer, Neighborhood House Head Start and Early Head Start: Family Wellness Night, 2010
Volunteer and supervisor, Hearing screens for Multnomah Head Start, 2009-2010

VI. TEACHING (OHSU Educators Portfolio):

Overview of your Role as an Educator:
Oregon Health and Science University promotes the integration of clinical care, teaching and research to improve the health of individuals, to educate clinicians and students, and to advance knowledge and science. My primary role in education is to teach, train and supervise Audiology graduate students during their Fourth Year Externship at OHSU. The Audiology department provides year-long externship experiences to two AuD students each year and I am the primary preceptor and coordinator. Our department also provides observation opportunities for 10-15 undergraduate and graduate students from Portland State University and Pacific University every year. I teach Advanced Audiology at Portland State University, and guest lectures at Pacific University and Portland State University.

Scholarship of Teaching:
Curriculum Development
SPHR 488 : Advanced Audiology, Portland State University, Department of Speech Communication, Speech and Hearing Science program, 4 credit course for undergraduate and post-baccalaureate students in Speech and Hearing Science, curriculum development, teaching, and evaluation. Winter 2010, 2011; Fall 2012, Spring 2013.

SPHR 575: Pediatric Audiology, Portland State University, Department of Speech Communication, Speech and Hearing Science program. 2 credit course for graduate students in Audiology, curriculum development, teaching, and evaluation. Fall 2003.

SPHR 577: Medical Audiology I, Portland State University, Department of Speech Communication, Speech and Hearing Science program. 4 credit course for graduate students in Audiology, curriculum development, teaching, and evaluation. Fall 2002.

Educational Activities
Audiology training coordinator, Leadership on Neurodevelopmental and Related Disabilities (LEND). Responsible for supervision and teaching of 4th Year Audiology Externs through practicum experience and LEND Fellowship; two externs each year. Observation experiences and teaching for LEND Fellows from other disciplines, medical students, pediatric residents, and nursing students.

Linking Science and Practice, LEND interdisciplinary didactic seminar.

OHSU Discover Careers - for Tomorrow's Health Professionals: provided presentations about the field of
Pediatric Audiology to high school students enrolled health-science track. 2009, 2011, 2012, 2013

Supervision and teaching: Auditory evoked potentials evaluation in rodents for research
assistants and post-doctoral fellows in Dr. Edward Neuwelt's lab. 2009-2011


Mentorship
Jessica Middaugh, LEND Audiology Extern, research project: Long-term hearing outcomes in survivors of childhood cancer, 2013

Shawn Kelly, Volunteer Research Assistant, January -June 2013. Shawn was an undergraduate student accepted to graduate school in Speech-Language Pathology. We met for 2-4 hours weekly and she learned about clinical research and assisted in data entry, literature review, study design and IRB application.

Madeline Howard, Research Assistant, June-September 2012. Maddie was an undergraduate student planning to apply to medical school in 2013. We met for 2-4 hours each week and she learned about pediatric audiology and clinical pediatric audiology research. She assisted in data entry, literature review, journal manuscript review, data analysis, and assisted in clinical evaluations of infants and children in the pediatric audiology clinic.

Kevin Still, LEND Audiology Extern, research project: Self-Report of Pediatric Hearing Aid Benefit by Parents and Children, 2012.

Dennis O'Loughlin, asked to provide peer review/mentorship for the Oregon Board of Examiners for Speech-Language Pathology and Audiology. Provided 20 hours of observation experience and instruction for a community audiologist at the request of the Board. Observation experiences included pediatric evaluations, discussion of pediatric test techniques and interpretation, protocols, counseling and recommendations, and direct instruction related to techniques and protocols for ABR evaluations and diagnosis/management of auditory neuropathy spectrum. 2010-2011

Michelle Pollihan, Lend Audiology Extern, research project: Long- term variability of distortion product otoacoustic emissions, 2007

Elsa Nelson, LEND Audiology Extern, research project: Test-retest variability of evoked distortion product otoacoustic emissions in children, 2006

Kristin Tomashiro, LEND Audiology Extern, research project: Ototoxicity in pediatric oncology patients, incidence and characteristics, 2005